Atomi Financial Group’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.67M Buy
30,578
+3,544
+13% +$543K 0.14% 128
2025
Q4
$3.73M Buy
27,034
+3,695
+16% +$484K 0.11% 145
2025
Q3
$2.99M Buy
23,339
+2,699
+13% +$329K 0.1% 153
2025
Q2
$2.5M Sell
20,640
-1,121
-5% -$126K 0.09% 156
2025
Q1
$2.43M Buy
21,761
+5,828
+37% +$620K 0.11% 145
2024
Q4
$1.55M Sell
15,933
-2,458
-13% -$262K 0.08% 187
2024
Q3
$2.12M Buy
18,391
+4,389
+31% +$498K 0.13% 130
2024
Q2
$1.49M Buy
14,002
+4,190
+43% +$421K 0.11% 150
2024
Q1
$949K Buy
9,812
+1,244
+15% +$128K 0.09% 188
2023
Q4
$865K Buy
+8,568
New +$827K 0.12% 155

Other funds holding NVS

Atomi Financial Group's NVS Position: Q1 2026 in Review

Atomi Financial Group increased its Novartis (NVS) stake by 13% in Q1 2026, buying an estimated $543K and bringing the position to 30,578 shares worth $4.67M. The position accounts for 0.14% of the portfolio, ranked #128.

Atomi Financial Group first reported a position in NVS in Q4 2023 and has held it in 10 quarters since. 1,590 funds tracked by Wall St. Rank hold NVS as of Q1 2026.

  • Atomi Financial Group held 30,578 shares of Novartis worth $4.67M as of Q1 2026.
  • Atomi Financial Group bought 3,544 Novartis shares in Q1 2026, an estimated $543K.
  • Novartis made up 0.14% of Atomi Financial Group's portfolio in Q1 2026, its #128 holding.
  • Atomi Financial Group first reported a position in Novartis in Q4 2023 and has held it in 10 quarters since.
  • 1,590 funds tracked by Wall St. Rank held Novartis as of Q1 2026.

Based on Atomi Financial Group's 13F filing for Q1 2026, filed 14 May 2026.